Analyst Ratings for Cincor Pharma Inc (CINC) [Neutrals]
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
1/12/2023 | Barclays | Leon Wang | Downgrade | Equalweight (Overweight) |
31.00 (22.00) |
28.80 (29.06) |
0.9% | Details |
11/29/2022 | Oppenheimer | Jay Olson | Downgrade | Perform (Outperform) |
N/A (N/A) |
26.53 (29.06) |
9.54% | Details |